Cover Image: August 2009 Scientific American Magazine See Inside

A Biochemical Way to Reduce Drug Side Effects? [Preview]

An emerging class of medicines works its magic by targeting unusual sites on biological molecules















Share on Tumblr



Theraputic agents known as allosteric ("other site") modulators take aim at targets outside of where classic drugs, and the body's own substances, normally hit selected molecules in the body. Image: Slim Films

In Brief

  • A new drug discovery approach focuses on a property known as allosterism.
  • Allosteric drugs attach to biological molecules at binding sites distinct from those usually targeted
    by medications.
  • Instead of activating or inhibiting the bound molecules, as classic drugs do, allosteric types can act more like dimmer switches and might, at times, cause fewer side effects.
  • Such agents may be able to treat disorders that lack drug therapies today.

Despite what the overcrowded, overpriced shelves of your pharmacy might suggest, pharmaceutical companies struggle to find new drugs these days. The low-hanging fruit is long gone, and the main discovery method that served so well in past decades is generating far fewer hits today. But a fresh strategy, focused on a property called allosterism, is now invigorating many investigators. Some predict it will revolutionize drug discovery and could deliver treatments for diseases that so far remain intractable.

Historically, scientists have developed drugs by finding molecules that mimic the behavior of our body's signaling molecules, such as hormones and neurotransmitters. The pharmaceutical doppelgangers of such endogenous substances latch onto cell-surface receptor molecules exactly where the native substances bind. If a mimic fits snugly into the binding pocket, known as the "active" site, it will activate the receptor, triggering a biochemical cascade within the cell. If the mimic has a slightly different shape, it will do the opposite, impeding the cascade. Most drugs on the market today—allergy medicines, beta blockers, antipsychotic drugs—act in one of those ways.


Subscribe     Buy This Issue

Already a Digital subscriber? Sign-in Now
If your institution has site license access, enter here.

2 Comments

Add Comment
View
  1. 1. dreamsammi 02:51 AM 8/11/09

    Great post and keep up the great job blogging!WOW. Nice written instructions.
    <a href="http://www.ed-hardy.cc/">ed hardy</a>
    <a href="http://www.edhardy-zone.com/">ed hardy</a><br>
    <a href="http://uggboots-zone.com/">ugg boots</a>

    Reply | Report Abuse | Link to this
  2. 2. dreamsammi 02:51 AM 8/11/09

    Great post and keep up the great job blogging!WOW. Nice written instructions.
    <a href="http://www.ed-hardy.cc/">ed hardy</a>
    <a href="http://www.edhardy-zone.com/">ed hardy</a><br>
    <a href="http://uggboots-zone.com/">ugg boots</a>

    Reply | Report Abuse | Link to this
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

See what we're tweeting about

Scientific American Editors

More »

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital

Latest from SA Blog Network

  SA Digital

Science Jobs of the Week

Email this Article

A Biochemical Way to Reduce Drug Side Effects?: Scientific American Magazine

X
Scientific American Magazine

Subscribe Today

Save 66% off the cover price and get a free gift!

Learn More >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X